Wu W - Search Results

1

Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic cancer.

Zeng L, Li J, Wang Y, Qian C, Chen Y, Zhang Q, Wu W, Lin Z, Liang J, Shuai X, Huang K. Zeng L, et al. Among authors: wu w. Nanomedicine. 2014 Feb;10(2):463-72. doi: 10.1016/j.nano.2013.08.007. Epub 2013 Sep 9. Nanomedicine. 2014. PMID: 24028894

2

Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.

Zeng L, Li J, Li J, Zhang Q, Qian C, Wu W, Lin Z, Liang J, Chen Y, Huang K. Zeng L, et al. Among authors: wu w. Pancreas. 2015 Mar;44(2):250-9. doi: 10.1097/MPA.0000000000000241. Pancreas. 2015. PMID: 25401377

3

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.

Huang J, Xiao Z, An Y, Han S, Wu W, Wang Y, Guo Y, Shuai X. Huang J, et al. Among authors: wu w. Biomaterials. 2021 Feb;269:120636. doi: 10.1016/j.biomaterials.2020.120636. Epub 2021 Jan 4. Biomaterials. 2021. PMID: 33453632

4

Recent development of gene therapy for pancreatic cancer using non-viral nanovectors.

Liu Y, Wu W, Wang Y, Han S, Yuan Y, Huang J, Shuai X, Peng Z. Liu Y, et al. Among authors: wu w. Biomater Sci. 2021 Oct 12;9(20):6673-6690. doi: 10.1039/d1bm00748c. Biomater Sci. 2021. PMID: 34378568 Review.

5

Correction: Recent development of gene therapy for pancreatic cancer using non-viral nanovectors.

Liu Y, Wu W, Wang Y, Han S, Yuan Y, Huang J, Shuai X, Zhao P. Liu Y, et al. Among authors: wu w. Biomater Sci. 2021 Oct 12;9(20):6966-6969. doi: 10.1039/d1bm90082j. Biomater Sci. 2021. PMID: 34546259

6

Case Report: Effectiveness of Targeted Treatment in a Patient With Pancreatic Cancer Harboring PALB2 Germline Mutation and KRAS Somatic Mutation.

Wu W, Liu Y, Jin Y, Liu L, Guo Y, Xu M, Hao Q, Li D, Fang W, Zhang A, Zhao P. Wu W, et al. Front Med (Lausanne). 2022 Jan 13;8:746637. doi: 10.3389/fmed.2021.746637. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35096857 Free PMC article.

7

Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy.

Guo Y, Liu Y, Wu W, Ling D, Zhang Q, Zhao P, Hu X. Guo Y, et al. Among authors: wu w. Biomaterials. 2021 Sep;276:121018. doi: 10.1016/j.biomaterials.2021.121018. Epub 2021 Jul 12. Biomaterials. 2021. PMID: 34284200 Review.

8

Molecular hydrogen: A potential radioprotective agent.

Hu Q, Zhou Y, Wu S, Wu W, Deng Y, Shao A. Hu Q, et al. Among authors: wu w, wu s. Biomed Pharmacother. 2020 Oct;130:110589. doi: 10.1016/j.biopha.2020.110589. Epub 2020 Aug 4. Biomed Pharmacother. 2020. PMID: 32763820 Free article. Review.

9

Cell delivery devices for cancer immunotherapy.

Wen P, Wu W, Wang F, Zheng H, Liao Z, Shi J, Zhu C, Zhao P, Cheng H, Li H, Gu Z. Wen P, et al. Among authors: wu w. J Control Release. 2023 Jan;353:875-888. doi: 10.1016/j.jconrel.2022.11.041. Epub 2022 Dec 19. J Control Release. 2023. PMID: 36442617 Review.

10

Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.

Bao X, Zhang H, Wu W, Cheng S, Dai X, Zhu X, Fu Q, Tong Z, Liu L, Zheng Y, Zhao P, Fang W, Liu F. Bao X, et al. Among authors: wu w. J Immunother Cancer. 2020 Oct;8(2):e001437. doi: 10.1136/jitc-2020-001437. J Immunother Cancer. 2020. PMID: 33028695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,817 results

Search Page

Filters